M&T Bank Corp Novo Nordisk A S Transaction History

M&T Bank Corp

$30.1 Billion
Q3 2024

A detailed history of M&T Bank Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, M&T Bank Corp holds 390,349 shares of NVO stock, worth $40.4 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

390,349

Previous 390,349 -0.0%

Holding current value

$40.4 Million

Previous $46.5 Million -0.0%

% of portfolio

0.15%

Previous 0.03%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$119.07 - $145.42 $277,075 - $338,392	-2,327 Reduced 0.59%	390,349 $46.5 Million
Q2 2024 Jul 31, 2024	BUY	$122.71 - $146.91 $32.7 Million - $39.2 Million	266,518 Added 211.26%	392,676 $56.1 Million
Q1 2024 May 07, 2024	SELL	$102.11 - $135.92 $764,803 - $1.02 Million	-7,490 Reduced 5.6%	126,158 $16.2 Million
Q4 2023 Feb 06, 2024	SELL	$87.78 - $105.45 $115,869 - $139,194	-1,320 Reduced 0.98%	133,648 $13.8 Million
Q3 2023 Nov 02, 2023	BUY	$90.94 - $199.54 $6.09 Million - $13.4 Million	66,933 Added 98.38%	134,968 $12.3 Million
Q2 2023 Aug 09, 2023	SELL	$155.98 - $172.65 $142,721 - $157,974	-915 Reduced 1.33%	68,035 $11 Million
Q1 2023 May 11, 2023	SELL	$132.34 - $159.14 $510,435 - $613,802	-3,857 Reduced 5.3%	68,950 $11 Million
Q4 2022 Feb 13, 2023	BUY	$102.55 - $135.33 $8.42 Million - $11.1 Million	82,104 Added 109.69%	156,956 $21.2 Million
Q4 2022 Feb 13, 2023	SELL	$102.55 - $135.33 $8.63 Million - $11.4 Million	-84,149 Reduced 53.61%	72,807 $9.85 Million
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $250,586 - $307,525	-2,630 Reduced 3.39%	74,852 $7.39 Million
Q2 2022 Aug 05, 2022	BUY	$103.24 - $121.81 $2.35 Million - $2.77 Million	22,749 Added 41.56%	77,482 $8.36 Million
Q1 2022 May 09, 2022	BUY	$93.1 - $112.54 $3.85 Million - $4.65 Million	41,353 Added 309.07%	54,733 $6.08 Million
Q4 2021 Feb 07, 2022	SELL	$95.88 - $117.08 $22,148 - $27,045	-231 Reduced 1.7%	13,380 $1.5 Million
Q3 2021 Oct 28, 2021	BUY	$84.42 - $106.62 $59,009 - $74,527	699 Added 5.41%	13,611 $1.31 Million
Q2 2021 Aug 13, 2021	SELL	$67.66 - $84.76 $1.29 Million - $1.62 Million	-19,081 Reduced 59.64%	12,912 $1.08 Million
Q1 2021 May 06, 2021	SELL	$67.06 - $75.82 $266,965 - $301,839	-3,981 Reduced 11.07%	31,993 $2.16 Million
Q4 2020 Feb 12, 2021	SELL	$63.89 - $73.8 $11,564 - $13,357	-181 Reduced 0.5%	35,974 $2.51 Million
Q3 2020 Nov 06, 2020	SELL	$63.69 - $70.22 $440,416 - $485,571	-6,915 Reduced 16.06%	36,155 $2.51 Million
Q2 2020 Jul 29, 2020	SELL	$58.54 - $67.94 $83,712 - $97,154	-1,430 Reduced 3.21%	43,070 $2.82 Million
Q1 2020 May 14, 2020	BUY	$49.46 - $64.78 $98,326 - $128,782	1,988 Added 4.68%	44,500 $2.68 Million
Q4 2019 Feb 07, 2020	BUY	$49.86 - $58.26 $107,548 - $125,666	2,157 Added 5.35%	42,512 $2.46 Million
Q3 2019 Nov 12, 2019	BUY	$47.54 - $53.43 $96,934 - $108,943	2,039 Added 5.32%	40,355 $2.09 Million
Q2 2019 Aug 12, 2019	BUY	$46.79 - $52.47 $62,417 - $69,994	1,334 Added 3.61%	38,316 $1.96 Million
Q1 2019 May 15, 2019	SELL	$46.36 - $52.63 $206,858 - $234,835	-4,462 Reduced 10.77%	36,982 $1.94 Million
Q4 2018 Feb 01, 2019	BUY	$41.54 - $47.25 $73,484 - $83,585	1,769 Added 4.46%	41,444 $1.91 Million
Q3 2018 Nov 09, 2018	SELL	$46.76 - $51.24 $29,037 - $31,820	-621 Reduced 1.54%	39,675 $1.87 Million
Q2 2018 Aug 10, 2018	BUY	$44.29 - $50.42 $9,433 - $10,739	213 Added 0.53%	40,296 $1.86 Million
Q1 2018 May 04, 2018	SELL	$48.49 - $58.14 $237,940 - $285,292	-4,907 Reduced 10.91%	40,083 $1.97 Million
Q4 2017 Feb 06, 2018	SELL	$47.53 - $53.73 $141,259 - $159,685	-2,972 Reduced 6.2%	44,990 $2.42 Million
Q3 2017 Nov 13, 2017	SELL	$41.15 - $49.22 $76,662 - $91,696	-1,863 Reduced 3.74%	47,962 $2.31 Million
Q2 2017 Aug 11, 2017	BUY	N/A	49,825	49,825 $2.14 Million

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $233B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account